Optomed Oyj (HEL:OPTOMED)

Optomed Oyj Statistics

Total Valuation

Optomed Oyj has a market cap or net worth of EUR 30.13 million. The enterprise value is 24.90 million.

Market Cap	30.13M
Enterprise Value	24.90M

Important Dates

The last earnings date was Wednesday, May 6, 2026.

Earnings Date	May 6, 2026
Ex-Dividend Date	n/a

Share Statistics

Optomed Oyj has 21.43 million shares outstanding. The number of shares has increased by 4.71% in one year.

Current Share Class	21.43M
Shares Outstanding	21.43M
Shares Change (YoY)	+4.71%
Shares Change (QoQ)	+2.24%
Owned by Insiders (%)	0.61%
Owned by Institutions (%)	34.01%
Float	16.19M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.83
PB Ratio	1.33
P/TBV Ratio	1.73
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-4.04
EV / Sales	1.52
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-5.23

Financial Position

The company has a current ratio of 2.51, with a Debt / Equity ratio of 0.11.

Current Ratio	2.51
Quick Ratio	2.00
Debt / Equity	0.11
Debt / EBITDA	n/a
Debt / FCF	-0.53
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -27.26% and return on invested capital (ROIC) is -14.81%.

Return on Equity (ROE)	-27.26%
Return on Assets (ROA)	-12.49%
Return on Invested Capital (ROIC)	-14.81%
Return on Capital Employed (ROCE)	-24.82%
Weighted Average Cost of Capital (WACC)	12.15%
Revenue Per Employee	148,000
Profits Per Employee	-55,495
Employee Count	111
Asset Turnover	0.54
Inventory Turnover	2.65

Taxes

Income Tax	-77,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -65.40% in the last 52 weeks. The beta is 1.62, so Optomed Oyj's price volatility has been higher than the market average.

Beta (5Y)	1.62
52-Week Price Change	-65.40%
50-Day Moving Average	2.26
200-Day Moving Average	3.37
Relative Strength Index (RSI)	25.16
Average Volume (20 Days)	146,033

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Optomed Oyj had revenue of EUR 16.43 million and -6.16 million in losses. Loss per share was -0.31.

Revenue	16.43M
Gross Profit	10.48M
Operating Income	-6.07M
Pretax Income	-6.24M
Net Income	-6.16M
EBITDA	-5.31M
EBIT	-6.07M
Loss Per Share	-0.31

Balance Sheet

The company has 7.75 million in cash and 2.52 million in debt, with a net cash position of 5.24 million or 0.24 per share.

Cash & Cash Equivalents	7.75M
Total Debt	2.52M
Net Cash	5.24M
Net Cash Per Share	0.24
Equity (Book Value)	22.72M
Book Value Per Share	1.12
Working Capital	8.34M

Cash Flow

In the last 12 months, operating cash flow was -4.29 million and capital expenditures -473,000, giving a free cash flow of -4.76 million.

Operating Cash Flow	-4.29M
Capital Expenditures	-473,000
Depreciation & Amortization	762,000
Net Borrowing	-1.27M
Free Cash Flow	-4.76M
FCF Per Share	-0.22

Margins

Gross margin is 63.82%, with operating and profit margins of -36.94% and -37.50%.

Gross Margin	63.82%
Operating Margin	-36.94%
Pretax Margin	-37.97%
Profit Margin	-37.50%
EBITDA Margin	-32.30%
EBIT Margin	-36.94%
FCF Margin	n/a

Dividends & Yields

Optomed Oyj does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-4.71%
Shareholder Yield	-4.71%
Earnings Yield	-20.44%
FCF Yield	-15.79%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	4